EAM

Eventide Asset Management Portfolio holdings

AUM $5.71B
This Quarter Return
+3.05%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$1.63B
AUM Growth
+$1.63B
Cap. Flow
-$164M
Cap. Flow %
-10.02%
Top 10 Hldgs %
31.09%
Holding
143
New
4
Increased
33
Reduced
15
Closed
14

Top Buys

1
FSLR icon
First Solar
FSLR
$22.5M
2
ARW icon
Arrow Electronics
ARW
$18.3M
3
WVE icon
Wave Life Sciences
WVE
$7.86M
4
HASI icon
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.08M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.72M

Top Sells

1
RHT
Red Hat Inc
RHT
$46.3M
2
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$29.1M
3
MDVN
MEDIVATION, INC.
MDVN
$20.1M
4
PANW icon
Palo Alto Networks
PANW
$17M
5
IMPV
Imperva, Inc.
IMPV
$16.3M

Sector Composition

1 Healthcare 31.3%
2 Technology 24.56%
3 Consumer Discretionary 12.61%
4 Industrials 7.43%
5 Utilities 5.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRTA icon
76
Prothena Corp
PRTA
$452M
$4.2M 0.26%
120,000
– –
AGTC
77
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3.94M 0.24%
279,100
– –
DVAX icon
78
Dynavax Technologies
DVAX
$1.19B
$3.65M 0.22%
250,000
– –
JUNO
79
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.46M 0.21%
90,000
– –
VYGR icon
80
Voyager Therapeutics
VYGR
$204M
$3.3M 0.2%
300,000
– –
TGTX icon
81
TG Therapeutics
TGTX
$5.03B
$3.26M 0.2%
537,600
– –
INCY icon
82
Incyte
INCY
$17B
$3.2M 0.2%
40,000
– –
CEMP
83
DELISTED
Cempra, Inc.
CEMP
$3.05M 0.19%
184,900
– –
RGEN icon
84
Repligen
RGEN
$6.54B
$3.01M 0.18%
110,000
– –
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$102B
$2.98M 0.18%
34,600
– –
GLPG icon
86
Galapagos
GLPG
$2.06B
$2.88M 0.18%
52,000
– –
NTUS
87
DELISTED
Natus Medical Inc
NTUS
$2.84M 0.17%
75,000
– –
EPZM
88
DELISTED
Epizyme, Inc
EPZM
$2.82M 0.17%
275,000
– –
GBT
89
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.74M 0.17%
165,000
– –
SYRS
90
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.72M 0.17%
+15,000
New +$2.72M
CDTX icon
91
Cidara Therapeutics
CDTX
$1.61B
$2.72M 0.17%
13,200
– –
TTPH
92
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.58M 0.16%
+30,000
New +$2.58M
ATRC icon
93
AtriCure
ATRC
$1.73B
$2.54M 0.16%
180,000
– –
CHRS icon
94
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$2.45M 0.15%
145,000
– –
KA
95
DELISTED
Kineta, Inc. Common Stock
KA
$2.43M 0.15%
1,429
– –
OMED
96
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.34M 0.14%
190,000
– –
TCON
97
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.27M 0.14%
2,589
– –
TNDM icon
98
Tandem Diabetes Care
TNDM
$834M
$2.07M 0.13%
27,500
+11,820
+75% +$891K
ARAY icon
99
Accuray
ARAY
$165M
$1.59M 0.1%
306,200
– –
CTMX icon
100
CytomX Therapeutics
CTMX
$350M
$1.53M 0.09%
150,000
– –
2 3
4
5 6